The pharmaceutical industry is a primary need because it is vital to Human beings who want to constantly improve their standard of living. This is a sector that is changing but is not likely to go down overnight. It is difficult for new players to enter especially due to high regulatory standards. Moreover with the technological evolution, it is a sector which has bright days in front of him. To survive in this sector, it will be necessary to focus on innovation and research & development. Discover pharmaceutical trends.
Currently, the growth of the pharmaceutical sector is still dynamic, but decreases compared to the beginning of the 2000s, reflecting the socio-economic changes to which the industry is subject. Discover the main trends below.
The digital age is giving the pharmaceutical industry new perspectives to explore. Take the example of Big Data, which allows better analysis of patients and their needs on the one hand and thus offer a more targeted and focused answer to the need. New technologies are enabling pharmaceutical industries to develop better drugs and medical equipment.
The generics directory, created and managed by the National Agency for the Safety of Medicines and Health Products (ANSM) in a rigorous public health approach, which builds stakeholder confidence, is made up of the generic groups representing the originator drug and its generics – marketed or not.
In 2016, it represents 5.5 billion euros in sales (2.0 billion for originals and 3.5 billion for generics), or 30% of the refundable market which is in perpetual increase.
The big pharmaceutical companies were up to now well organized for the production of “blockbusters”, with production sites that could be dedicated to a single product. This model has lived. Today’s medicines are produced in smaller volumes. They require less active ingredients (around 10 to 20 t / year maximum) but with often more complex synthesis. This would require transforming the single-product plants of major pharmaceutical companies into multi-product plants. But it is a weakness of pharmaceutical companies to set up flexible plants able of managing several products at the same time. On the other hand, this is the CDMO know-how to manage simultaneously many products, in particular in small volumes.
This shift in focus will allow the pharmaceutical industry to provide comprehensive care management. If it has to do so, it will have to rebuild its image because many healthcare professionals and patients no longer believe the industry can provide such services unless they are certain that it brings their essential needs to the heart of its strategy concerns.
The ever-increasing appeal of all age people for well-being products only reinforces the growing trend in the pharmaceutical world. Well-being is a turning point for pharmaceutical companies now and in the coming years.
Be accompanied to face all these mutations!